245 reports of this reaction
1.6% of all BUPIVACAINE reports
#11 most reported adverse reaction
LABELLED DRUG DRUG INTERACTION MEDICATION ERROR is the #11 most commonly reported adverse reaction for BUPIVACAINE, manufactured by Pacira Pharmaceuticals, Inc.. There are 245 FDA adverse event reports linking BUPIVACAINE to LABELLED DRUG DRUG INTERACTION MEDICATION ERROR. This represents approximately 1.6% of all 15,404 adverse event reports for this drug.
Patients taking BUPIVACAINE who experience labelled drug drug interaction medication error should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LABELLED DRUG DRUG INTERACTION MEDICATION ERROR is a less commonly reported adverse event for BUPIVACAINE, but still significant enough to appear in the safety profile.
In addition to labelled drug drug interaction medication error, the following adverse reactions have been reported for BUPIVACAINE:
The following drugs have also been linked to labelled drug drug interaction medication error in FDA adverse event reports:
LABELLED DRUG DRUG INTERACTION MEDICATION ERROR has been reported as an adverse event in 245 FDA reports for BUPIVACAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LABELLED DRUG DRUG INTERACTION MEDICATION ERROR accounts for approximately 1.6% of all adverse event reports for BUPIVACAINE, making it a notable side effect.
If you experience labelled drug drug interaction medication error while taking BUPIVACAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.